Long-term subcutaneous treprostinil therapy evokes both survival benefits and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension

被引:0
|
作者
Vachiery, JL [1 ]
Gautier, MT [1 ]
Huez, S [1 ]
Retailleau, K [1 ]
Naeije, R [1 ]
机构
[1] Erasme Univ Hosp, Dept Cardiol, B-1070 Brussels, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1849
引用
收藏
页码:400 / 400
页数:1
相关论文
共 50 条
  • [41] Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy
    Speich, R
    Jenni, R
    Opravil, M
    Jaccard, R
    SWISS MEDICAL WEEKLY, 2001, 131 (45-46) : 663 - 665
  • [42] LONG TERM SURVIVAL AND TRANSPLANT RATES IN PULMONARY ARTERIAL HYPERTENSION PATIENTS TREATED WITH PARENTERAL PROSTACYCLIN THERAPY
    Ghosh, Sudeshna
    Shah, Trushil
    Bartolome, Sonja
    Gordon, Rhoda Annoh
    Chin, Kelly
    CHEST, 2020, 158 (04) : 2262A - 2263A
  • [43] Long-Term Ambrisentan Therapy in Patients with Pulmonary Arterial Hypertension: An Analysis by WHO Functional Class
    Torres, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [44] Dose-Dependent Improvement in Survival with ACE Inhibitor Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
    Shore, S.
    Aggarwal, V.
    Zolty, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S226 - S226
  • [45] Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension
    Stiebellehner, L
    Petkov, V
    Vonbank, K
    Funk, G
    Schenk, P
    Ziesche, R
    Block, LH
    CHEST, 2003, 123 (04) : 1293 - 1295
  • [46] Screening for Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis Clinical Characteristics at Diagnosis and Long-Term Survival
    Humbert, Marc
    Yaici, Azzedine
    de Groote, Pascal
    Montani, David
    Sitbon, Olivier
    Launay, David
    Gressin, Virginie
    Guillevin, Loic
    Clerson, Pierre
    Simonneau, Gerald
    Hachulla, Eric
    ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3522 - 3530
  • [47] Long-term benefits of sildenafil treatment on health-related quality of life in patients with pulmonary arterial hypertension
    Pepke-Zaba, J
    Other, MCB
    Parpia, T
    Burgess, CGG
    CHEST, 2005, 128 (04) : 161S - 161S
  • [48] Long-term therapy with oral treprostinil in pulmonary arterial hypertension failed to lead to improvement in important physiologic measures: results from a single center
    Chin, Kelly Marie
    Ruggiero, Rosechelle
    Bartolome, Sonja
    Velez-Martinez, Mariella
    Darsaklis, Konstantina
    Kingman, Martha
    Harden, Scarlet
    Torres, Fernando
    PULMONARY CIRCULATION, 2015, 5 (03) : 513 - 520
  • [49] Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension A Randomized Trial
    Simonneau, Gerald
    Rubin, Lewis J.
    Galie, Nazzareno
    Barst, Robyn J.
    Fleming, Thomas R.
    Frost, Adaani E.
    Engel, Peter J.
    Kramer, Mordechai R.
    Burgess, Gary
    Collings, Lorraine
    Cossons, Nandini
    Sitbon, Olivier
    Badesch, David B.
    ANNALS OF INTERNAL MEDICINE, 2008, 149 (08) : 521 - W102
  • [50] Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Marra, Alberto M.
    Egenlauf, Benjamin
    Ehlken, Nicola
    Fischer, Christine
    Eichstaedt, Christina
    Nagel, Christian
    Bossone, Eduardo
    Cittadini, Antonio
    Halank, Michael
    Gall, Henning
    Olsson, Karen M.
    Lange, Tobias J.
    Gruenig, Ekkehard
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 195 : 19 - 26